Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Pfizer Manufacturing Belgium NV
EIR
•Pfizer Manufacturing Belgium NV•July 2, 2021

Pfizer Manufacturing Belgium NV – FDA EIR, Jul 2, 2021

Record Details

This FDA establishment inspection report details a pre-license inspection of Pfizer Manufacturing Belgium NV, located in Puurs, Belgium. The inspection, conducted from June 24 to July 2, 2021, evaluated the facility for the manufacturing, fill/finish, and labeling/packaging of COMIRNATY™ (COVID-19 Vaccine) under a Biologics License Application (BLA). The regulatory framework for this inspection falls under the FDA's oversight for biological products. Significantly, the inspection concluded without the issuance of an FDA Form 483, "Inspectional Observations," indicating no major regulatory violations were identified by the agency. The inspection covered critical systems including Quality, Facilities/Equipment, Production, Materials, Packaging/Labeling, and Laboratory Control. While no formal FDA observations were issued, the company had previously investigated internal deviations, such as batches demonstrating lower than expected potency due to raw material impurities, leading to process revisions. Other internal deviations included issues with a specific assay and non-inspected vials being labeled, prompting internal corrective actions and revisions to procedures as part of their ongoing quality management system.

Company
Pfizer Manufacturing Belgium NV
Inspection date
July 2, 2021
Product type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Anissa Cheung (investigator)
  • Susan M. Jackson (investigator)
  • Zhongren Wu (Principal Consultant)
  • Laura Fontan (investigator)
  • Luc Van Steenwinkel (recipient)
View Company Profile

ID · 63404e90-f447-48cd-9cf0-fba58c2cde32

Violation Codes2
21 CFR 820.19821 CFR 820.50

Full citation text and observation details available on the Dashboard.

Other documents for Pfizer Manufacturing Belgium NV
  • EIR - 2024-06-28June 28, 2024
  • 483 - 2024-05-17May 17, 2024
  • 483 - 2023-06-08June 8, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pfizer Manufacturing Belgium NV
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.